關於課程
We have state-of-the-art research facilities and funding from sources including MRC, BBSRC, Wellcome Trust, NIHR, Wolfson Foundation and the EU.
Our focus is on research that is directed towards understanding disease processes, defining therapeutic strategies for intervention, and the scientific basis of drug safety. The ultimate aim of this research is to translate laboratory findings into the clinic for the benefit of patients, the public and the healthcare system.
Our research specifically focuses on the following areas:
Drug Safety Science - We undertake fundamental clinical and basic research into the causes, characteristics and consequences of adverse drug reactions to improve the benefit-risk ratio of current and new medicines
Personalized Medicine – We aim to identify the specific differences which cause individuals to respond to drugs differently
Immuno-pharmacology - We undertake basic and clinical research to characterize drug interactions with immune cells and identify novel drug targets
The Pharmacology of Infectious Disease – We aim to understand the molecular mechanisms underlying the variability in response to HIV, tuberculosis and hepatitis therapy
Nanomedicines – We investigate the application of nanomedicines in infectious disease
Neuropharmacology – We are working to discover the underlying causes of common nervous system disorders, examine their consequences and identify new treatments.
Drug Safety Science Adverse reactions are a significant problem for patients, healthcare systems and the pharmaceutical industry. Recognizing its excellence in the field of drug safety science, the MRC awarded the department a Centre grant. The MRC Centre for Drug Safety Science is the only Centre of its kind in Europe. We carry out clinical and basic research into the causes, characteristics and consequences of adverse drug reactions and focus on the mechanisms and genetic predisposition of adverse reactions to drugs. Our mission is to improve diagnosis and clinical handling of these reactions.
Personalised Medicine – Personalized medicine has the power to revolutionize the way in which serious diseases are treated in the UK and beyond. Working from the Wolfson Centre for Personalised Medicine, the Departments research focuses on identifying predictive genetic markers for drug responses associated with clinical areas including cardiovascular disease, asthma and epilepsy. Clinical and basic scientists are dedicated to detecting genes and pathways that can determine a patient’s response to a drug. The ultimate aim of our research is to translate laboratory findings into clinical care for the benefit of patients and healthcare systems.
- 獎學金 - 查看所有獎學金
開始日期及學費
如何申請
Entry requirements for 利物浦大學
Applicants for postgraduate research study at Liverpool are normally expected to hold a UK first degree with a First Class or Upper Second Class degree classification, or a Second Class degree plus a Master’s degree. Equivalent international qualifications are also accepted, and their equivalence will be evaluated on the basis of the information provided by the National Academic Recognition and Information Centre (NARIC) as well as internal guidance based on our experience of a qualification’s suitability as a preparation for our programmes. To complete the online application, you'll need: School or college transcripts/ certificates, University transcripts, Degree certificates, School of Histories, Languages and Cultures require: Ielts - 6.5 with minimum 6.0 in each component. If IELTS requirement 6.5 with 6.0 in all bands then TOEFL IBT requirement is min 88 overall with 21-Listening, Writing, 22-Reading, 23-Speaking. 88 with minimum band scores of Listening 21, Writing 21, Reading 22, Speaking 23
English language requirements
托福(TOEFL iBT)總分: 88.0
最後申請期限:
這個日期的預約已滿,聯絡IDP的顧問以獲得詳細資訊
更多資訊
近期活動
想了解更多關於此處的資訊?請看 IDP如何蒐集並展示課程資訊. 此處的資訊內容若有誤,IDP不負任何責任與義務。建議您直接洽詢IDP的專業顧問,以獲得最新最準確的資訊。
我們開始吧!
一鍵註冊或登入
檢視清單 或關閉此視窗以繼續搜尋